The Joint Corp.
NASDAQ:JYNTMedical - Care Facilities
+$0.17 today
- Market cap
- $91.03M
- Beta
- 1.10
- P/E (TTM)
- 40.7
- EPS (TTM)
- $0.23
Volume 0.05M
Average 0.07M
JYNT Gross Profit
Revenue minus cost of revenue: what remains to cover operating expenses after paying for what was sold.
The Joint Corp.NASDAQ: JYNT
Gross Profit · Q1 FY2026 · quarter ended Mar 2026
Gross profit grows, but more slowly than its trailing trend
Q1 FY2026 gross profit of $11.7M rose 15.8% year over year, behind the +674.7% change in trailing-twelve-month gross profit. Sequentially, it fell 5.2% from the prior quarter. Over 3 fiscal years it compounded at -22.0% a year.
Context
- Gross profit amounted to 79.6% of revenue in FY2025, up 1.6 pp from a year earlier.
- Gross profit increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +15.8% toward the trailing-twelve-month pace of +674.7%.
Sources:Income StatementText generated from reported figures; not investment advice.
Gross Profit history
USD · from the income statement
- Latest · FY2025
- 43.67M USD
- Year-over-year change
- +7.4%
- 4-year CAGR
- -11.9%
| Period | Period end | Gross Profit | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 43.67M | +7.4% |
| FY2024 | 2024-12-31 | 40.65M | +11.4% |
| FY2023 | 2023-12-31 | 36.5M | -60.4% |
| FY2022 | 2022-12-31 | 92.08M | +27.3% |
| FY2021 | 2021-12-31 | 72.35M | — |
Gross Profit vs competitors
How JYNT compares with its peers on the latest reported figures
- JYNT's LTM Mar 2026 gross profit of $45.27M is the 3rd highest of the 11 companies compared; the peer median is $2.13M.
- Its year-over-year change of +674.7% is the highest of 10, against a peer median of -8.8%.
- Gross profit amounts to 79.9% of revenue for JYNT, versus a peer median of 36.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $128.8M | -8.8% | +6.7% | 68.5% | |
| LTM Mar 2026 | $89.15M | -49.7% | -13.9% | 29.5% | |
| LTM Mar 2026 | $45.27M | +674.7% | -22.0% | 79.9% | |
| LTM Mar 2026 | $39.3M | -23.5% | +1.0% | 31.7% | |
| LTM Mar 2026 | $18.04M | -26.0% | -13.2% | 32.3% | |
| LTM Mar 2026 | $4.26M | +134.5% | — | 12.4% | |
| LTM Mar 2026 | $0 | +100.0% | — | — | |
| LTM Mar 2026 | -$109K | -1190.0% | — | 191.2% | |
| LTM Mar 2026 | -$129K | — | — | — | |
| LTM Mar 2026 | -$423.12K | +33.2% | — | 106.6% | |
| LTM Mar 2026 | -$2.06M | +27.2% | — | 40.0% | |
| Peer median (excluding JYNT) | $2.13M | -8.8% | -6.1% | 36.1% | |
Competitors are the stored peer set for JYNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 80.01M | 101.25M | 46.98M | 52.16M | 54.9M |
| Cost of Revenue | 7.67M | 9.17M | 10.48M | 11.52M | 11.23M |
| Gross Profit | 72.35M | 92.08M | 36.5M | 40.65M | 43.67M |
| Gross Margin | 90.4% | 90.9% | 77.7% | 77.9% | 79.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 62.27M | 81.95M | 34.92M | 41.1M | 42.93M |
| Operating Expenses | 66.22M | 91.25M | 36.18M | 42.54M | 44.58M |
| Depreciation & Amortization | 3.92M | 6.65M | 8.58M | 4.72M | 1.71M |
| EBITDA | 10.07M | 7.89M | 8.88M | 2.9M | 1.48M |
| EBITDA Margin | 12.6% | 7.8% | 18.9% | 5.6% | 2.7% |
| Operating Income | 6.13M | 828.25K | 318.3K | (1.89M) | (905.48K) |
| Operating Margin | 7.7% | 0.8% | 0.7% | -3.6% | -1.6% |
| Interest Income | 0 | 133.1K | 0 | 280.29K | 0 |
| Interest Expense | 0 | 953.53K | 64.29K | 0 | 0 |
| Other Income / Expenses | (69.88K) | (133.1K) | (64.29K) | 280.29K | 675.97K |
| Income Before Tax | 6.06M | 695.15K | 254.01K | (1.61M) | (229.5K) |
| Pre-Tax Margin | 7.6% | 0.7% | 0.5% | -3.1% | -0.4% |
| Income Tax Expense | (1.51M) | 68.45K | 11.02M | 5.61K | 38.65K |
| Net Income | 7.57M | 626.71K | (9.75M) | (5.8M) | 2.91M |
| Net Margin | 9.5% | 0.6% | -20.8% | -11.1% | 5.3% |
| EPS (Basic) | 0.46 | 0.04 | (0.66) | (0.39) | 0.19 |
| EPS (Diluted) | 0.44 | 0.04 | (0.66) | (0.39) | 0.19 |
| Weighted Avg Shares | 14.32M | 14.49M | 14.69M | 14.92M | 15.13M |
| Weighted Avg Shares (Diluted) | 14.94M | 14.87M | 14.69M | 15.15M | 15.13M |
The Joint Corp.
NASDAQ:JYNT
Intrinsic Alpha fair value
Locked
Current Price
$6.65
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.